Pediatric Device Articles & Analysis
21 news found
” The EvoEndo® Single-Use Endoscopy System received FDA 510(k) clearance in February 2022 and the company is executing a rollout of this novel TNE device to both pediatric and adult patients this year. While traditional endoscopy requires patients to undergo general anesthesia or sedation, the EvoEndo System combines sterile, single-use, flexible ...
ByEvoEndo
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are ...
“We were honored by the invitation to provide a Pediatric Device Spotlight on our TOMi Scope [OtoSight Middle Ear Scope] in the Spring Newsletter,” said Ryan Nolan, VP of Clinical Operations & Co-founder. “The newsletter is a great means for the Pediatrics community to learn about promising technology advancements, like ...
(NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and nView medical, a Salt Lake City-based company developing surgical imaging and guidance systems enabled by artificial intelligence (AI), today announced a partnership and investment agreement to jointly develop and co-market the innovative nView systems with Orthofix cervical spine and ...
” The nView s1 with true-map navigation™ was first unveiled at the Pediatric Orthopedic Society of North America (POSNA) 2021 annual meeting. ...
atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced the appointment of Andrew Cleeland to the company’s Board of Directors. ...
MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around the globe. ...
MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around the globe. ...
2021 Cohort to Prominently Feature the Industry’s Best and Brightest Startups Working to Transform Patient Care Through Innovation LOS ANGELES — June 15, 2021 — MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase ...
Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures. ...
Berlin Heart is pleased to announce that the first patients are enrolled in the "E-MOTION" study: “The use of the EXCOR® Active driving unit for MObilizaTION of pediatric patients with Ventricular Assist Device support”. This observational, international, multi-center study investigates the improved mobility, patient outcome and the impact of ...
The cannula is designed to reduce the complexity of surgery, improve the sub-pulmonary hemodynamics and enable the end-organ recovery. The Pediatric Heart-Team from the LMU University Hospital Munich was the first to use this device. The specialized pediatric cardiac surgical team led by Prof. Juergen Hoerer (Pediatric Heart ...
Xeltis bio-restorative pulmonary heart valves and their clinical outcomes will feature at the upcoming Pediatric Device Innovators Forum organized by the U.S. Food and Drug Administration (FDA) in conjunction with five U.S. pediatric device consortia on 11 March. “I am looking forward to discussing the potential and the ...
” The potential of nView medical’s insta-3D™ imaging is especially exciting for Children’s National as nView medical is a 2019 Winner of the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) competition "Make Your Medical Device Pitch for Kids!" ...
CoapTech Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded CoapTech a two-year, $1.6M R44 Small Business Innovation Research (SBIR) Phase II grant on September 22, 2020 to finalize development of and trial its Pediatric PUMA-G System. This new grant builds on a prior ...
ByCoapTech
nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology. nView medical backers include the National Science Foundation (NSF), the National Institutes of ...
” competition presented by FDA-sponsored National Capital Consortium for Pediatric Device Innovation. The competition focused on innovations in COVID-19-related pediatric medical devices that will improve children’s health care, with 16 finalists competing in a virtual pitch event for a share of $250,000 in total ...
PAO surgery aims to preserve the hip joint by repositioning the native acetabulum, a complex pediatric joint preservation surgery that aims to reduce or eliminate the risk of a future total hip replacement. ...
“Current tools can only provide a view of the surface of the eardrum, forcing healthcare providers to make an assessment with very limited information, or to employ invasive surgical procedures to accurately identify middle ear pathologies,” said Diego Preciado, M.D., Ph.D. of the Children’s National Hospital in Washington, D.C., a lead investigator for clinical studies of the ...
Current data shows needle sticks per PIVC for complex children is 6 compared to the average of 2, the average dwell time to be only 50 hours and that 50% of these devices fail. In addition, 1 in 4 central venous access devices (CVADs) fail prior to completion of therapy. With this poor performance of vascular access devices in ...